vs
Side-by-side financial comparison of AVALON HOLDINGS CORP (AWX) and ARS Pharmaceuticals, Inc. (SPRY). Click either name above to swap in a different company.
ARS Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($28.1M vs $21.5M, roughly 1.3× AVALON HOLDINGS CORP). AVALON HOLDINGS CORP runs the higher net margin — -1.7% vs -147.1%, a 145.5% gap on every dollar of revenue. On growth, AVALON HOLDINGS CORP posted the faster year-over-year revenue change (21.7% vs -67.6%).
Avalon Hill Games Inc. is a game company that publishes wargames and strategic board games. It has also published miniature wargaming rules, role-playing games and sports simulations. It is a subsidiary of Hasbro, and operates under the company's "Hasbro Gaming" division.
ARS Pharmaceuticals, Inc. is a late-stage biopharmaceutical firm specializing in the development and commercialization of novel therapies for severe allergic reactions, most notably needle-free epinephrine delivery solutions for anaphylaxis. It primarily operates in the North American market, catering to both pediatric and adult patient groups at risk of life-threatening allergic responses.
AWX vs SPRY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.5M | $28.1M |
| Net Profit | $-356.0K | $-41.3M |
| Gross Margin | 17.1% | — |
| Operating Margin | 0.4% | -147.6% |
| Net Margin | -1.7% | -147.1% |
| Revenue YoY | 21.7% | -67.6% |
| Net Profit YoY | 28.4% | -182.8% |
| EPS (diluted) | — | $-0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.5M | $28.1M | ||
| Q3 25 | $25.7M | $32.5M | ||
| Q2 25 | $20.3M | $15.7M | ||
| Q1 25 | $16.1M | $8.0M | ||
| Q4 24 | $17.6M | $86.6M | ||
| Q3 24 | $24.2M | $2.1M | ||
| Q2 24 | $23.1M | $500.0K | ||
| Q1 24 | $18.9M | $0 |
| Q4 25 | $-356.0K | $-41.3M | ||
| Q3 25 | $1.9M | $-51.2M | ||
| Q2 25 | $274.0K | $-44.9M | ||
| Q1 25 | $-1.5M | $-33.9M | ||
| Q4 24 | $-497.0K | $49.9M | ||
| Q3 24 | $1.8M | $-19.1M | ||
| Q2 24 | $954.0K | $-12.5M | ||
| Q1 24 | $-979.0K | $-10.3M |
| Q4 25 | 17.1% | — | ||
| Q3 25 | 23.7% | — | ||
| Q2 25 | 20.6% | — | ||
| Q1 25 | 14.8% | — | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | 24.6% | — | ||
| Q2 24 | 22.1% | — | ||
| Q1 24 | 16.2% | — |
| Q4 25 | 0.4% | -147.6% | ||
| Q3 25 | 9.1% | -163.7% | ||
| Q2 25 | 3.7% | -302.9% | ||
| Q1 25 | -7.2% | -466.3% | ||
| Q4 24 | -0.8% | 54.5% | ||
| Q3 24 | 9.4% | -1051.6% | ||
| Q2 24 | 6.3% | -3068.0% | ||
| Q1 24 | -2.7% | — |
| Q4 25 | -1.7% | -147.1% | ||
| Q3 25 | 7.4% | -157.4% | ||
| Q2 25 | 1.4% | -285.6% | ||
| Q1 25 | -9.3% | -425.7% | ||
| Q4 24 | -2.8% | 57.7% | ||
| Q3 24 | 7.6% | -925.0% | ||
| Q2 24 | 4.1% | -2503.2% | ||
| Q1 24 | -5.2% | — |
| Q4 25 | — | $-0.41 | ||
| Q3 25 | — | $-0.52 | ||
| Q2 25 | — | $-0.46 | ||
| Q1 25 | — | $-0.35 | ||
| Q4 24 | — | $0.52 | ||
| Q3 24 | — | $-0.20 | ||
| Q2 24 | — | $-0.13 | ||
| Q1 24 | — | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $245.0M |
| Total DebtLower is stronger | — | $96.4M |
| Stockholders' EquityBook value | $38.4M | $114.3M |
| Total Assets | $87.4M | $327.7M |
| Debt / EquityLower = less leverage | — | 0.84× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | $245.0M | ||
| Q3 25 | $4.6M | $288.2M | ||
| Q2 25 | $3.7M | $240.1M | ||
| Q1 25 | $1.3M | $275.7M | ||
| Q4 24 | $2.8M | $314.0M | ||
| Q3 24 | $3.9M | $204.6M | ||
| Q2 24 | $3.8M | $218.7M | ||
| Q1 24 | $1.2M | $223.6M |
| Q4 25 | — | $96.4M | ||
| Q3 25 | — | $96.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $38.4M | $114.3M | ||
| Q3 25 | $38.7M | $147.7M | ||
| Q2 25 | $36.8M | $192.3M | ||
| Q1 25 | $36.5M | $229.0M | ||
| Q4 24 | $38.0M | $256.8M | ||
| Q3 24 | $38.5M | $201.0M | ||
| Q2 24 | $36.7M | $215.2M | ||
| Q1 24 | $35.7M | $223.9M |
| Q4 25 | $87.4M | $327.7M | ||
| Q3 25 | $90.7M | $372.8M | ||
| Q2 25 | $88.1M | $313.5M | ||
| Q1 25 | $87.6M | $327.3M | ||
| Q4 24 | $86.2M | $351.2M | ||
| Q3 24 | $89.1M | $217.6M | ||
| Q2 24 | $91.7M | $222.0M | ||
| Q1 24 | $90.6M | $227.6M |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $278.0K | $-43.5M |
| Free Cash FlowOCF − Capex | $-166.0K | — |
| FCF MarginFCF / Revenue | -0.8% | — |
| Capex IntensityCapex / Revenue | 2.1% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.0K | $-43.5M | ||
| Q3 25 | $1.5M | $-47.0M | ||
| Q2 25 | $3.0M | $-39.6M | ||
| Q1 25 | $-982.0K | $-40.7M | ||
| Q4 24 | $-579.0K | $42.0M | ||
| Q3 24 | $342.0K | $-14.5M | ||
| Q2 24 | $3.2M | $-7.3M | ||
| Q1 24 | $411.0K | $-6.7M |
| Q4 25 | $-166.0K | — | ||
| Q3 25 | $852.0K | $-47.2M | ||
| Q2 25 | $2.7M | $-39.6M | ||
| Q1 25 | $-1.4M | $-40.8M | ||
| Q4 24 | $-1.1M | $41.7M | ||
| Q3 24 | $-660.0K | $-14.6M | ||
| Q2 24 | $2.9M | $-7.3M | ||
| Q1 24 | $56.0K | $-6.8M |
| Q4 25 | -0.8% | — | ||
| Q3 25 | 3.3% | -145.4% | ||
| Q2 25 | 13.5% | -252.2% | ||
| Q1 25 | -8.5% | -512.1% | ||
| Q4 24 | -6.4% | 48.2% | ||
| Q3 24 | -2.7% | -706.3% | ||
| Q2 24 | 12.4% | -1463.4% | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 2.1% | 0.0% | ||
| Q3 25 | 2.3% | 0.6% | ||
| Q2 25 | 1.4% | 0.3% | ||
| Q1 25 | 2.4% | 1.1% | ||
| Q4 24 | 3.1% | 0.3% | ||
| Q3 24 | 4.1% | 6.8% | ||
| Q2 24 | 1.5% | 7.6% | ||
| Q1 24 | 1.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.76× | — | ||
| Q2 25 | 11.07× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.84× | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 3.35× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AWX
Segment breakdown not available.
SPRY
| Products | $20.3M | 72% |
| Other | $7.8M | 28% |
